id_pmc	sentence location	highlighted phrase	protein entities found	number of protein entities
3474199	abstract	One|substitution|,|T|for|S|at|position|112|(|S112T|)|,|enhance|tumor|cell|recognition|by|CD8+|lymphocyte|,|and|a|second|dually|substitute|receptor|(|S112T|L110F|)|enhance|tumor|cell|recognition|by|CD4+|T|cell|.	position|112|S112T	3
6921533	body	Currently|,|TCR|-|base|immunotherapy|in|clinical|trial|primarily|focus|on|tumor|-|associate|antigen|and|CT|antigen|(|Table|1|)|.Table|1Information|of|clinical|trial|of|TCR|-|engineer|T|cellsAntigenAmino|acid|sequence|of|peptideMHC|moleculeCancerTCR|usedObjective|clincial|responseToxicityNumber|of|patientsReferencesMART|-|1AAGIGILTVHLA|-|A|*|0201MelanomaDMF4|(|human|)|2|/|17|(|12|%|)|None17103MART|-|1AAGIGILTVHLA|-|A|*|0201MelanomaDMF5|(|human|)|6|/|20|(|30|%|)|On|-|target|toxicity|on|normal|melanocyte|(|Skin|rash|(|14|/|20|)|,|Uveitis|(|11|/|20|)|,|Hear|impairment|(|10|/|20|)|)|20105MART|-|1EAAGIGILTVHLA|-|A|*|0201Metastatic|melanoma1D3HMCys|(|human|)|9|/|13|(|69|%|)|Mild|skin|rash|(|3|/|13|)|serious|adverse|event|(|2|/|13|)|due|to|cytokine|release|syndrome13106gp100KTWGQYWQVHLA|-|A|*|0201Melanomagp100|-|154|(|mouse|)|3|/|16|(|17|%|)|On|-|target|toxicity|on|normal|melanocyte|(|Skin|rash|(|15|/|16|)|,|Uveitis|(|4|/|16|)|,|Hear|impairment|(|5|/|16|)|)|16103NY|-|ESO|-|1SLLMWITQCHLA|-|A|*|0201Melanoma1G4|-|α95|:|LY|(|human|)|5|/|11|(|45|%|)|None11108Synovial|sarcoma4|/|6|(|67|%|)|6CEAIMIGVLVGVHLA|-|A|*|0201Metastatic|colorectal|cancerL110F|/|S112T|(|mouse|)|1|/|3|(|33|%|)|Severe|inflammatory|colitis|(|3|/|3|)|due|to|on|-|target|toxicity|in|colon3113MAGE|-|A3KVAELVHFLHLA|-|A|*|0201Metastatic|melanomaMAGE|-|A3|A118T|(|mouse|)|5|/|9|(|56|%|)|Central|nervous|system|toxicity|(|Necrotize|leukoencephalopathy|and|death|(|2|/|9|)|,|Parkinson|-|like|symptom|(|1|/|9|)|,|Aphasia|(|1|/|9|)|)|due|to|recognition|of|MAGE|-|A12|in|the|brain7114Synovial|sarcoma1Esophageal|cancer1MAGE|-|A3EVDPIGHLYHLA|-|A|*|01Ulcerate|melanomaMAGE|-|A3a3a|(|human|)|NACardiac|toxicity|and|death|(|2|/|2|)|due|to|cross|-|recognition|of|an|unrelated|epitope|from|Titin|(|TTN|)|1119Myeloma1MAGE|-|A4NYKRCFPVIHLA|-|A|*|2402Esophageal|cancerMS|-|bPa|(|human|)|0|/|10|(|0|%|)|None10115NY|-|ESO|-|1SLLMWITQCHLA|-|A|*|0201Synovial|cell|sarcoma1G4|-|α95|:|LY|(|human|)|11|/|18|(|61|%|)|None18116Melanoma11|/|20|(|55|%|)|20NY|-|ESO|-|1SLLMWITQCHLA|-|A|*|0201Multiple|myelomaNY|-|ESOc259|(|human|)|16|/|20|(|80|%|)|None20117WT1CMTWNQMNLHLA|-|A|*|2402AML|and|MDSpMS3|-|WT1|-|siTCR|(|human|)|2|/|8|(|25|%|)|None8118|Morgan|et|al|.	TCR|CT|antigens|TCR|0201MelanomaDMF4|(|human|)|2|0201MelanomaDMF5|(|human|)|6|cytokine|0201Melanomagp100|-|154|(|mouse|)|3|ESO|LY|(|human|)|5|S112T|(|mouse|)|1|A3KVAELVHFLHLA|A3|A118T|(|mouse|)|5|A12|A3EVDPIGHLYHLA|TTN|A4NYKRCFPVIHLA|bPa|(|human|)|0|ESO|ESO|ESOc259|siTCR|(|human|)|2	57
6368608	body	Analysis|of|VL|elbow|region|sequence|reveal|few|mutation|,|suggest|mutation|in|the|VH|elbow|region|be|the|dominant|source|of|elbow|conformational|control|in|bnAb|development|(|Supplementary|Table|7|)|.Table|3BnAb|elbow|region|mutation|frequenciesbnAbEpitope|%|FWR|%|ElbowVH|Elbow|MutationsVH|*|*|*|VH|*|VH8ANC131CD4|BS3142.9A9G|,|E10G|*|,|V11L|*|*|*|,|T107S|,|T110I|*|*|*|,|S112T|*|*|*|316CH103CD4|BS20.742.9L11V|*|*|*|,|P14S|,|T107S|,|T110S|*|*|*|,|S112T|*|*|*|,|S113A|*|316VRC13.01CD4|BS44.857.1A9T|,|E10A|*|,|V11M|*|*|*|,|K13S|,|P14L|,|L108F|,|T110R|*|*|*|,|S113P|*|228N6CD4|BS3142.9A9T|,|E10A|*|,|V11M|*|*|*|,|M108T|,|T110V|*|*|*|,|S113A|*|226VRC01CD4|BS34.535.7A9G|,|E10Q|*|,|V11M|*|*|*|,|L108P|,|T110I|*|*|*|215VRC16.01CD4|BS19.528.6L11F|*|*|*|,|Q13K|,|T110I|*|*|*|,|S113A|*|214CH235.12CD4|BS36.850A9G|,|E10G|*|,|K13R|,|P14L|,|T107S|,|L108P|,|T110I|*|*|*|117VRC27.01CD4|BS34.535.7A9P|,|E10Q|*|,|K12R|*|,|L108R|,|T110V|*|*|*|125VRC|-|CH31CD4|BS29.928.6E10A|*|,|K12R|*|,|L108P|,|T110V|*|*|*|124VRC18.02CD4|BS29.928.6A9N|,|E10Q|*|,|K12R|*|,|T110I|*|*|*|124NIH45|-|46CD4|BS35.635.7A9G|,|E10Q|*|,|V11M|*|*|*|,|T107A|,|L108P1151B2530CD4|BS32.228.6A9T|,|E10A|*|,|K12R|*|,|T107S0243BNC117CD4|BS28.721.4E10A|*|,|K12T|*|,|L108Q0233BNC60CD4|BS32.221.4E10A|*|,|K12T|*|,|L108Q0238ANC195gp120|-|gp4135.628.6A9T|,|V109I|*|,|T110S|*|*|*|,|S113A|*|12435O22gp120|-|gp4126.414.3V11L|*|*|*|,|V109L|*|112PGT151gp120|-|gp4116.10–000VRC34gp4119.57.1T108S001DH511.2MPER19.57.1T110I|*|*|*|1012F5MPER11.521.4T10P|*|,|T107I|,|V111I|*|0234E10MPER10.37.1K13R00110E8MPER20.70–000PGDM1400Glycan|V1|/|V232.221.4A9P|,|K12R|*|,|T108A013PGT145Glycan|V1|/|V220.77.1T108A001PG9Glycan|V1|/|V213.80–000CH01Glycan|V1|/|V226.421.4G9A|,|G10N|*|,|T110S|*|*|*|113BF520Glycan|V35.721.4V11M|*|*|*|,|K13M|,|T110S|*|*|*|203DH270.6Glycan|V317.228.6E10Q|*|,|V11M|*|*|*|,|K13N|,|V109L|*|124PGT128Glycan|V324.121.4G10T|*|,|K13E|,|P14A013PGT135Glycan|V321.814.3T107V|,|L108Q002PGT121Glycan|V320.77.1T108Q0012G12Glycan|V329.921.4P14A|,|M108V|,|S113|*|013VH|framework|and|elbow|region|mutation|frequency|(|%|)|be|relative|to|the|unmutated|common|ancestor|.	E10G|*|V11L|T107S|T110I|*|*|*|S112T|*|P14S|T107S|T110S|*|*|*|S112T|*|*|*|E10A|V11M|*|*|*|K13S|P14L|L108F|T110R|S113P|E10A|V11M|*|*|*|M108T|T110V|*|*|*|E10Q|V11M|*|*|*|L108P|Q13K|T110I|*|*|*|E10G|*|K13R|P14L|T107S|L108P|E10Q|K12R|L108R|K12R|L108P|E10Q|K12R|124NIH45|E10Q|V11M|*|*|*|T107A|E10A|K12R|L108Q0233BNC60CD4|BS32.221.4E10A|*|L108Q0238ANC195gp120|gp4135.628.6A9T|V109I|*|T110S|*|*|*|S113A|*|12435O22gp120|gp4126.414.3V11L|V109L|*|112PGT151gp120|gp4116.10–000VRC34gp4119.57.1T108S001DH511.2MPER19.57.1T110I|*|*|*|1012F5MPER11.521.4T10P|V111I|V232.221.4A9P|K12R|V226.421.4G9A|G10N|*|K13M|V11M|*|*|*|K13N|V109L|K13E|P14A013PGT135Glycan|V321.814.3T107V|L108Q002PGT121Glycan|V320.77.1T108Q0012G12Glycan|V329.921.4P14A|M108V|S113|*|013VH|framework	120
